Wolverine Trading
PTX

Wolverine Trading’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Wolverine Trading’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-10,585
Closed -$39K – 5439
2017
Q1 		$39K Buy
+10,585
New +$33.2K ﹤0.01% 4038

Other funds holding PTX

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wolverine Trading's PTX Position: Q2 2017 in Review

Wolverine Trading sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q2 2017, closing a stake of 10,585 shares — an estimated $39K sold.

Wolverine Trading first reported a position in PTX in Q1 2017 and held it in 1 quarter. The position peaked at $39K in Q1 2017. 30 funds tracked by Wall St. Rank hold PTX as of Q2 2017.

  • Wolverine Trading reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q2 2017 after selling out during the quarter.
  • Wolverine Trading sold 10,585 Pernix Therapeutics Holdings, Inc. shares in Q2 2017, an estimated $39K.
  • Wolverine Trading first reported a position in Pernix Therapeutics Holdings, Inc. in Q1 2017 and held it in 1 quarter.
  • Wolverine Trading's Pernix Therapeutics Holdings, Inc. position peaked at $39K in Q1 2017.
  • 30 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q2 2017.

Based on Wolverine Trading's 13F filing for Q2 2017, filed 14 Aug 2017.